Asio Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Asio Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,995	Closed	-$2.44M	–	114
2021 Q2	$2.44M	Buy	17,995 +1,609	+10%	+$212K	0.86%	55
2021 Q1	$2.22M	Buy	16,386 +6,816	+71%	+$1.02M	0.92%	60
2020 Q4	$1.35M	Buy	9,570 +540	+6%	+$69.2K	0.65%	61
2020 Q3	$1.01M	Buy	9,030 +6,329	+234%	+$710K	0.55%	61
2020 Q2	$302K	Buy	+2,701	New	+$266K	0.19%	66

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Asio Capital's XBI Position: Q3 2021 in Review

Asio Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 17,995 shares — an estimated $2.44M sold.

Asio Capital first reported a position in XBI in Q2 2020 and held it in 5 quarters. The position peaked at $2.44M in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Asio Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
Asio Capital sold 17,995 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $2.44M.
Asio Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 5 quarters.
Asio Capital's State Street SPDR S&P Biotech ETF position peaked at $2.44M in Q2 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Asio Capital's 13F filing for Q3 2021, filed 1 Nov 2021.